Cell culture and purification process--purity and safety testing.
作者信息
Koplove H M
机构信息
Genetics Institute, Cambridge, MA 01240.
出版信息
Ann Hematol. 1994;68 Suppl 3(Suppl 3):S15-20. doi: 10.1007/BF01774524.
Abstract
摘要
相似文献
1
Cell culture and purification process--purity and safety testing.细胞培养与纯化过程——纯度与安全性检测。
Ann Hematol. 1994;68 Suppl 3(Suppl 3):S15-20. doi: 10.1007/BF01774524.
2
Immobilized animal cell bioreactors.
Bioprocess Technol. 1995;21:377-411.
3
Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.生物技术与血浆分馏行业——凝血因子VIII生产进展的影响
Australas Biotechnol. 1993 Jan-Feb;3(1):16-20.
4
Recombinate: viral safety and final product manufacturing testing and specifications.
Ann Hematol. 1994;68 Suppl 3:S21-4. doi: 10.1007/BF01774525.
5
Design and operation of a recombinant mammalian cell manufacturing process for rFVIII.
Ann Hematol. 1994;68 Suppl 3:S9-14. doi: 10.1007/BF01774523.
6
Optimization of a roller bottle process for the production of recombinant erythropoietin.
Ann N Y Acad Sci. 1992 Oct 13;665:127-36. doi: 10.1111/j.1749-6632.1992.tb42580.x.
7
Safety and economic aspects of continuous mammalian cell culture.哺乳动物细胞连续培养的安全性和经济方面。
J Biotechnol. 1992 Jan;22(1-2):51-68. doi: 10.1016/0168-1656(92)90132-s.
8
The manufacturing of the recombinant factor VIII, Kogenate.
Transfus Med Rev. 1992 Oct;6(4):256-60. doi: 10.1016/s0887-7963(92)70177-1.
9
The manufacturing process of recombinant factor VIII, recombinate.
Transfus Med Rev. 1992 Oct;6(4):247-51. doi: 10.1016/s0887-7963(92)70175-8.
10
Production and characterization of recombinant factor VIII.
Semin Hematol. 1991 Apr;28(2 Suppl 1):17-21.
引用本文的文献
1
Evaluation of genetic stability of recombinant human factor VIII by peptide mapping and on-line mass spectrometric analysis.通过肽图分析和在线质谱分析评估重组人凝血因子VIII的遗传稳定性。
Pharm Res. 1997 Aug;14(8):1092-8. doi: 10.1023/a:1012169832299.
Zotero 插件